Coronavirus tally: FDA panel to review Moderna vaccine for children aged 6 to 17

An independent panel of advisers to the Food and Drug Administration will meet later Tuesday to discuss the use of the Moderna vaccine in children aged 6 to 17. If the panel offers a favorable opinion, the Moderna vaccine could become a second choice along with the Pfizer vaccine that was granted authorization last June for 12- to 15-year-olds. The meeting will be followed on Wednesday by one that will review both Moderna and Pfizer vaccines for children below the age of five, the last group to be added to the vaccine program.
U.S. cases are averaging 16,795 a day, down 2% from two weeks ago, [l: according to a New York Times tracker. The country is averaging 29,642 hospitalizations a day, up 9% from two weeks ago. The daily death toll has fallen to 324 on average, down 12% from two weeks ago. On a global basis, total cases are now above 535.8 million. Total deaths are above 6.31 million, according to data aggregated by Johns Hopkins University, with the U.S. still leading the way with 85.6 million cases and 1,011,543 deaths.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.